Total Payments
$19,051
2024 Payments
$2,976
Companies
62
Transactions
1,258
Medicare Patients
4,473
Medicare Billing
$170,629
Payment Breakdown by Category
Food & Beverage$18,948 (99.5%)
Education$102.83 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,948 | 1,247 | 99.5% |
| Education | $102.83 | 11 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,588 | 123 | $0 (2024) |
| Novo Nordisk Inc | $1,958 | 148 | $0 (2024) |
| Lilly USA, LLC | $1,956 | 134 | $0 (2024) |
| PFIZER INC. | $1,568 | 131 | $0 (2024) |
| ABBVIE INC. | $1,452 | 91 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,397 | 95 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $902.65 | 48 | $0 (2023) |
| Merck Sharp & Dohme LLC | $893.86 | 76 | $0 (2024) |
| GlaxoSmithKline, LLC. | $687.28 | 48 | $0 (2024) |
| Amgen Inc. | $576.92 | 37 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,976 | 169 | Novo Nordisk Inc ($364.46) |
| 2023 | $2,771 | 177 | ABBVIE INC. ($497.46) |
| 2022 | $1,605 | 96 | ABBVIE INC. ($318.96) |
| 2021 | $2,143 | 131 | Lilly USA, LLC ($373.20) |
| 2020 | $1,776 | 125 | AstraZeneca Pharmaceuticals LP ($287.28) |
| 2019 | $2,699 | 180 | AstraZeneca Pharmaceuticals LP ($533.27) |
| 2018 | $2,341 | 181 | Novo Nordisk Inc ($359.52) |
| 2017 | $2,738 | 199 | AstraZeneca Pharmaceuticals LP ($598.64) |
All Payment Transactions
1,258 individual payment records from CMS Open Payments — Page 5 of 51
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Diabetes | ||||||
| 05/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.15 | General |
| 05/15/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Genetic Disease | ||||||
| 05/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Respiratory | ||||||
| 05/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: PAIN | ||||||
| 05/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.87 | General |
| 05/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: RESPIRATORY | ||||||
| 05/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: DIABETES | ||||||
| 05/03/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Iron Deficiency Anemia | ||||||
| 04/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Diabetes | ||||||
| 04/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Diabetes | ||||||
| 04/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: RESPIRATORY | ||||||
| 04/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Neurology | ||||||
| 04/14/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: HIV | ||||||
| 04/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Biological | ||||||
| 04/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Obesity | ||||||
| 04/08/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Bone Health | ||||||
| 04/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,235 | 1,743 | $134,644 | $59,526 |
| 2022 | 26 | 1,089 | 1,626 | $116,253 | $34,138 |
| 2021 | 20 | 937 | 1,355 | $100,372 | $38,698 |
| 2020 | 23 | 1,212 | 1,756 | $112,141 | $38,267 |
Total Patients
4,473
Total Services
6,480
Medicare Billing
$170,629
Procedure Codes
92
All Medicare Procedures & Services
92 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 153 | 354 | $71,862 | $29,624 | 41.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 65 | 65 | $13,455 | $8,087 | 60.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 81 | $11,664 | $4,587 | 39.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 41 | 41 | $3,280 | $2,949 | 89.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 53 | 66 | $5,346 | $1,915 | 35.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 91 | 128 | $4,608 | $1,670 | 36.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 104 | 192 | $2,304 | $1,605 | 69.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 77 | 87 | $4,002 | $1,432 | 35.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 93 | 139 | $4,031 | $1,432 | 35.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 47 | 47 | $1,927 | $1,398 | 72.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 64 | 64 | $1,856 | $1,131 | 60.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 54 | 98 | $2,548 | $926.45 | 36.4% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 64 | 83 | $1,494 | $526.22 | 35.2% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 26 | 28 | $1,148 | $413.84 | 36.0% |
| 82746 | Folic acid level, serum | Office | 2023 | 24 | 24 | $960.00 | $345.84 | 36.0% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 35 | 42 | $672.00 | $233.85 | 34.8% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 13 | 16 | $592.00 | $213.76 | 36.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 34 | 41 | $574.00 | $204.81 | 35.7% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 13 | 16 | $560.00 | $200.00 | 35.7% |
| 83540 | Iron level | Office | 2023 | 27 | 30 | $540.00 | $190.20 | 35.2% |
| 80069 | Kidney function blood test panel | Office | 2023 | 14 | 20 | $480.00 | $170.20 | 35.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 62 | 64 | $384.00 | $140.80 | 36.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 16 | 17 | $357.00 | $129.37 | 36.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 118 | 290 | $56,431 | $14,160 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 69 | $9,576 | $3,164 | 33.0% |
About Dr. Teresa Marshall, M.D
Dr. Teresa Marshall, M.D is a Family Medicine healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346257565.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Teresa Marshall, M.D has received a total of $19,051 in payments from pharmaceutical and medical device companies, with $2,976 received in 2024. These payments were reported across 1,258 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($18,948).
As a Medicare-enrolled provider, Marshall has provided services to 4,473 Medicare beneficiaries, totaling 6,480 services with total Medicare billing of $170,629. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Kansas City, MO
- Active Since 08/01/2006
- Last Updated 10/07/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1346257565
Products in Payments
- FARXIGA (Drug) $1,641
- TRULICITY (Drug) $978.40
- JARDIANCE (Drug) $820.65
- Ozempic (Drug) $783.43
- VRAYLAR (Drug) $749.01
- XARELTO (Drug) $560.77
- CHANTIX (Drug) $516.83
- JANUVIA (Drug) $515.16
- MOUNJARO (Drug) $447.12
- SYMBICORT (Drug) $414.88
- ELIQUIS (Drug) $373.10
- INVOKANA (Drug) $341.88
- GEMTESA (Drug) $312.58
- Kerendia (Drug) $301.99
- TRADJENTA (Drug) $295.14
- Victoza (Drug) $283.77
- UBRELVY (Drug) $276.45
- Morphabond ER (Drug) $253.58
- Saxenda (Drug) $250.41
- BELSOMRA (Drug) $240.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Kansas City
Dr. Meredith Levine, M.d, M.D
Family Medicine — Payments: $38,004
Family Medicine $38,004
Eric Aspinwall, Md, MD
Family Medicine — Payments: $33,048
Family Medicine $33,048
Dr. Maurice Blodgett, D.o, D.O
Family Medicine — Payments: $30,998
Family Medicine $30,998
Dr. Blair Thedinger
Family Medicine — Payments: $19,784
Family Medicine $19,784
Dr. Julie Alvarez, Md, MD
Family Medicine — Payments: $19,673
Family Medicine $19,673
Michael Simanovsky, M.d, M.D
Family Medicine — Payments: $16,366
Family Medicine $16,366